Written by : Nikita Saha
January 30, 2025
He has also strengthened Cipla’s trade generics business through direct customer engagement and has driven strategic partnerships with multinational corporations, positioning Cipla as a preferred partner for in-licensing deals and innovation portfolios.
Cipla has appointed Achin Gupta as its new Global Chief Operating Officer (COO). Gupta, who joined Cipla in 2021 as CEO of the One India Business, has played a key role in the company’s growth, driving double-digit revenue expansion and strengthening profitability.
His leadership has reinforced Cipla’s position as the top-ranked pharmaceutical company by volume.
As a member of Cipla’s Management Council, Gupta has led the company’s transformation in India by deepening its presence in chronic therapies, expanding operations into Tier 2-6 cities, and establishing category leadership in wellness brands.
He has also strengthened Cipla’s trade generics business through direct customer engagement and has driven strategic partnerships with multinational corporations, positioning Cipla as a preferred partner for in-licensing deals and innovation portfolios.
Gupta has emphasized Cipla’s commitment to a patient-centric, purpose-driven approach. His initiatives, including the launch of Cipla Digital Health and the Retail Task Force, along with various consumer-focused programs, have gained industry recognition for their impact and innovation.
“The need for a unified, integrated healthcare system in India is more urgent than ever. Patients often suffer from long wait times and inefficient service delivery due to outdated healthcare infrastructure. India has long needed a comprehensive healthcare solution to address inefficiencies in service delivery, particularly in rural and underserved regions. We aim to close these gaps by launching a unified healthtech platform that connects patients, doctors, and healthcare institutions. We believe this will improve access to care, streamline workflows, and reduce wait times, directly saving lives and easing pressure on the country’s healthcare system. We believe that Lytus HealthTech will ensure that both patients and doctors have the tools they need for timely, accurate, and efficient medical care. Our goal is to help elevate the standard of healthcare in India, bringing it in line with global best practices,” said Dharmesh Pandya, CEO of Lytus Technologies.
Gupta holds an M.Tech degree in Biochemical Engineering and Biotechnology from IIT Delhi and an MBA from IIM Ahmedabad. With over two decades of experience, he has built a strong track record as an entrepreneurial leader, launching and scaling businesses across India, Europe, and emerging markets.